AKT1 and glaucoma: Inhibitors of PI3K/Akt/mTOR pathway have been extensively investigated in cancer therapy [34] Therefore, PI3K/Akt/mTOR axis may have a central role in regulating the over-expression of ECM genes and over-proliferation found in glaucoma LC cells.